ACIP: Updated Vaccine Guidance for the 2021-2022 Influenza Season
Routine annual vaccination is recommended for all patients 6 months of age and older who have no contraindications.
Routine annual vaccination is recommended for all patients 6 months of age and older who have no contraindications.
Experts in the field of obstetrics and epidemiology share how they are helping their patients make informed clinical decisions about vaccination for SARS-CoV-2.
Investigators assessed response to vaccination with the Moderna or Pfizer-BioNTech COVID-19 vaccines in pregnant and nonpregnant lactating women.
The extension was based on data from ongoing stability assessment studies.
Clinicians report the cutaneous reactions experienced by healthcare workers who received the Pfizer COVID-19 vaccine.
The report included 10262 SARS-CoV-2 vaccine breakthrough infections in 46 US states and territories among 101 million fully vaccinated individuals as of April 30, 2021.
The TeenCOVE study (ClinicalTrials.gov: NCT04649151) included over 3700 US adolescents aged 12 to less than 18 years.
The safety of the vaccine in this patient population was based on data from 2260 adolescent participants.
Investigators vaccinated exclusively or partially breastfeeding women and examined their breast milk samples to determine levels of antibodies against SARS-CoV-2.
With many Americans awaiting to be vaccinated, while others indicating they are unlikely to get the jab, we spoke with 2 experts for their perspectives regarding this controversial topic.